UnitedHealth Group reported second-quarter earnings that significantly exceeded analysts' expectations, with adjusted earnings per share of $6.38 compared to the anticipated $4.90. The company also raised its full-year adjusted earnings forecast to between $19.50 and $20 per share, up from over $18.25.
Despite these positive results, CFO Wayne DeVeydt noted that medical costs remain high, which has been a persistent issue for the insurance industry. The company’s revenue for the quarter reached $112.03 billion, surpassing the expected $110.85 billion. UnitedHealth's stock rose approximately 7% in premarket trading following the announcement.
The company is implementing a turnaround strategy that includes restructuring and investing $1.5 billion in artificial intelligence to enhance operational efficiency and patient care.
While the medical benefit ratio improved to 86.7%, indicating better profitability, DeVeydt warned that rising healthcare costs are leading to premium increases and membership losses, particularly in ACA exchange plans and Medicare Advantage. The company anticipates a decline of about 500,000 ACA members and 1.1 million Medicare Advantage members by 2026.
Overall, while UnitedHealth's current performance is strong, the long-term outlook remains uncertain due to ongoing cost pressures and regulatory scrutiny